% | $
Quotes you view appear here for quick access.

Optimer Pharmaceuticals, AŞ Message Board

  • chuckpalot chuckpalot Nov 4, 2011 8:43 AM Flag

    Baird Pipes In - - Raisies Price Target To $19

    Baird maintains an 'Outperform' on Optimer Pharmaceuticals (NASDAQ: OPTR) price target raised $1 to $19.

    Baird analyst says, "Dificid sales were a little better than recent consensus, but following the 9/12 positive, partial pre-announce, we sensed investors were more focused on what Q4 might look like and on underlying demand trends. The Q3 update contained constructive datapoints and clues on underlying demand trends. We came away reinforced in thinking Q4 is tracking well and fundamental growth will remain healthy."

    SortNewest  |  Oldest  |  Most Replied Expand all replies